{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T20:52:16Z","timestamp":1779223936204,"version":"3.51.4"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T00:00:00Z","timestamp":1677024000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.msard.2023.104583","type":"journal-article","created":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T03:25:00Z","timestamp":1676949900000},"page":"104583","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Comparing the risk of serious infections in patients with and without MS: A German claims data analysis"],"prefix":"10.1016","volume":"72","author":[{"given":"Rachel","family":"Knapp","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fr\u00e4nce","family":"Hardtstock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8932-6426","authenticated-orcid":false,"given":"Thomas","family":"Wilke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulf","family":"Maywald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cathy","family":"Chognot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Licinio","family":"Craveiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erwan Muros-Le","family":"Rouzic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"18","key":"10.1016\/j.msard.2023.104583_bib0001","first-page":"e1810","article-title":"The sUnited States","volume":"98","author":"Bebo","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2023.104583_bib0002","article-title":"Risk of serious infections in multiple sclerosis patients by disease course and disability status: results from a Swedish register-based study","volume":"22","author":"Brand","year":"2022","journal-title":"Brain Behav. Immun. Health."},{"key":"10.1016\/j.msard.2023.104583_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102420","article-title":"Infections in patients with multiple sclerosis: a national cohort study in Sweden","volume":"45","author":"Castelo-Branco","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"8","key":"10.1016\/j.msard.2023.104583_bib0004","doi-asserted-by":"crossref","first-page":"e820","DOI":"10.1212\/WNL.0000000000008907","article-title":"Multiple cause of death analysis in multiple sclerosis: a population-based study","volume":"94","author":"Harding","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2023.104583_bib0005","unstructured":"Holstiege J, Steffen A, Goffrier B, B\u00e4tzing J. Epidemiologie der Multiplen Sklerose-eine populationsbasierte deutschlandweite Studie. wwwversorgungsatlasde. 12\/07 2017;Versorgungsatlas-Report:1\u201316. doi:10.20364\/VA-17.09."},{"issue":"6 Suppl","key":"10.1016\/j.msard.2023.104583_bib0006","first-page":"s141","article-title":"Overview and diagnosis of multiple sclerosis","volume":"22","author":"Hunter","year":"2016","journal-title":"Am. J. Manage. Care"},{"key":"10.1016\/j.msard.2023.104583_bib0007","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.00156","article-title":"60\/30: 60% of the Morbidity-associated multiple sclerosis disease burden comes from the 30% of Persons with higher impairments","volume":"11","author":"Kaufmann","year":"2020","journal-title":"Front. Neurol."},{"issue":"2","key":"10.1016\/j.msard.2023.104583_bib0008","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000504804","article-title":"Causes that contribute to the excess mortality risk in multiple sclerosis: a population-based study","volume":"54","author":"Kingwell","year":"2020","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.msard.2023.104583_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.104245","article-title":"Serious infections in patients with relapsing and progressive forms of multiple sclerosis: a German claims data study","volume":"68","author":"Knapp","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"7","key":"10.1016\/j.msard.2023.104583_bib0010","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1111\/j.1468-1331.2012.03668.x","article-title":"Causes of death in patients with multiple sclerosis and matched referent subjects: a population-based cohort study","volume":"19","author":"Lalmohamed","year":"2012","journal-title":"Eur. J. Neurol."},{"issue":"11","key":"10.1016\/j.msard.2023.104583_bib0011","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1177\/13524585221094218","article-title":"Mapping the risk of infections in patients with multiple sclerosis: a multi-database study in the United Kingdom clinical practice research datalink GOLD and aurum","volume":"28","author":"Leung","year":"2022","journal-title":"Mult. Scler. J."},{"issue":"8","key":"10.1016\/j.msard.2023.104583_bib0012","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1136\/jnnp-2016-315238","article-title":"Survival and cause of death in multiple sclerosis: a 60-year longitudinal population study","volume":"88","author":"Lunde","year":"2017","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"10","key":"10.1016\/j.msard.2023.104583_bib0013","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1212\/WNL.0000000000000753","article-title":"Dramatically changing rates and reasons for hospitalization in multiple sclerosis","volume":"83","author":"Marrie","year":"2014","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.msard.2023.104583_bib0014","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1111\/ene.12130","article-title":"Hospital admission due to infections in multiple sclerosis patients","volume":"20","author":"Montgomery","year":"2013","journal-title":"Eur. J. Neurol."},{"issue":"5","key":"10.1016\/j.msard.2023.104583_bib0015","doi-asserted-by":"crossref","first-page":"221","DOI":"10.7224\/1537-2073.2014-035","article-title":"Multiple sclerosis and risk of infection-related hospitalization and death in US veterans","volume":"17","author":"Nelson","year":"2015","journal-title":"Int. J. MS Care"},{"key":"10.1016\/j.msard.2023.104583_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.101982","article-title":"Infections in patients diagnosed with multiple sclerosis: a multi-database study","volume":"41","author":"Persson","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"2","key":"10.1016\/j.msard.2023.104583_bib0017","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1212\/WNL.0b013e31829a3388","article-title":"Mortality in patients with multiple sclerosis","volume":"81","author":"Scalfari","year":"2013","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.msard.2023.104583_bib0018","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13690-021-00561-z","article-title":"Health-related quality of life of multiple sclerosis patients: a European multi-country study","volume":"79","author":"Visser","year":"2021","journal-title":"Arch. Public Health"},{"issue":"14","key":"10.1016\/j.msard.2023.104583_bib0019","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1177\/1352458520970841","article-title":"Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition","volume":"26","author":"Walton","year":"2020","journal-title":"Mult. Scler"},{"issue":"11","key":"10.1016\/j.msard.2023.104583_bib0020","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1177\/1352458516681198","article-title":"Infection-related health care utilization among people with and without multiple sclerosis","volume":"23","author":"Wijnands","year":"2017","journal-title":"Mult. Scler."},{"issue":"10","key":"10.1016\/j.msard.2023.104583_bib0021","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1136\/jnnp-2017-317493","article-title":"Disease-modifying drugs for multiple sclerosis and infection risk: a cohort study","volume":"89","author":"Wijnands","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034823000871?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034823000871?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T09:05:44Z","timestamp":1761901544000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034823000871"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":21,"alternative-id":["S2211034823000871"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2023.104583","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparing the risk of serious infections in patients with and without MS: A German claims data analysis","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2023.104583","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104583"}}